Featuring a slide presentation and related discussion from Dr Hope S Rugo, including the following topics:
- Current treatment landscape for and outcomes in HR-positive, HER2-negative metastatic breast cancer (mBC) (0:00)
- Trastuzumab deruxtecan for HER2-low and HER2-ultralow mBC (7:49)
- Sacituzumab govitecan for HR-positive, HER2-negative mBC (20:44)
- Datopotamab deruxtecan for HR-positive, HER2-negative mBC (27:29)
- Novel antibody-drug conjugates under investigation for HR-positive mBC (33:19)
Fler avsnitt av Research To Practice | Oncology Videos
Visa alla avsnitt av Research To Practice | Oncology VideosResearch To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
